Inge Cuppen

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications

Lung Function and Respiratory Muscle Strength in Symptomatic Children and Adults With Spinal Muscular Atrophy Treated With Nusinersen.

Lung Function and Respiratory Muscle Strength in Symptomatic Children and Adults With Spinal Muscular Atrophy Treated With Nusinersen.

Journal: Neurology
Published: May 07, 2026

Motor function score changes in severe 5q spinal muscular atrophy during risdiplam treatment: an observational longitudinal nationwide cohort study.

Motor function score changes in severe 5q spinal muscular atrophy during risdiplam treatment: an observational longitudinal nationwide cohort study.

Journal: EClinicalMedicine
Published: January 20, 2026

Impaired renal function in patients with spinal muscular atrophy: A longitudinal cohort study.

Impaired renal function in patients with spinal muscular atrophy: A longitudinal cohort study.

Journal: Journal of neuromuscular diseases
Published: January 16, 2026

A de novo deletion underlying spinal muscular atrophy: implications for carrier testing and genetic counseling.

A de novo deletion underlying spinal muscular atrophy: implications for carrier testing and genetic counseling.

Journal: Human molecular genetics
Published: January 30, 2025

Sensory Nerve Action Potential Analysis in a Cohort of Patients With Spinal Muscular Atrophy Aged 12 Years and Older.

Sensory Nerve Action Potential Analysis in a Cohort of Patients With Spinal Muscular Atrophy Aged 12 Years and Older.

Journal: Muscle & nerve
Published: September 11, 2024

Phenotype Spectrum of TRPM3-Associated Disorders.

Phenotype Spectrum of TRPM3-Associated Disorders.

Journal: Annals of neurology
Published: June 25, 2024

Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3.

Exploring functional strength changes during nusinersen treatment in symptomatic children with SMA types 2 and 3.

Journal: Neuromuscular disorders : NMD
Published: April 24, 2024

Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRI.

Monitoring Nusinersen Treatment Effects in Children with Spinal Muscular Atrophy with Quantitative Muscle MRI.

Journal: Journal of neuromuscular diseases
Published: December 11, 2023

Swallowing Problems in Spinal Muscular Atrophy Types 2 and 3: A Clinical, Videofluoroscopic and Ultrasound Study.

Swallowing Problems in Spinal Muscular Atrophy Types 2 and 3: A Clinical, Videofluoroscopic and Ultrasound Study.

Journal: Journal of neuromuscular diseases
Published: April 03, 2023

Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol.

Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol.

Journal: BMC neurology
Published: March 14, 2023

Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study.

Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study.

Journal: Orphanet journal of rare diseases
Published: September 20, 2022

Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment.

Inflammatory markers in cerebrospinal fluid of paediatric spinal muscular atrophy patients receiving nusinersen treatment.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: July 21, 2022
Showing 1-12 of 52

Last Updated: 09/26/2026